Jellyfish Sting Anaphylaxis – A Comprehensive Medical Guide

Overview

Jellyfish sting anaphylaxis is a severe, life‑threatening allergic reaction that can occur after the skin is pierced by the nematocysts (stinging cells) of certain jellyfish species. While most jellyfish encounters cause mild skin irritation, a small but important subset of individuals experience systemic hypersensitivity that rapidly escalates to anaphylaxis.

Who it affects: Anyone can be stung, but anaphylaxis is more common in people with a prior history of allergic reactions, asthma, or previous jelly‑fish sensitization. Epidemiologic data from coastal regions (e.g., the Gulf of Mexico, the Indo‑Pacific, and the Mediterranean) suggest that approximately 5–8 % of serious jellyfish envenomations involve anaphylaxis [1].

Prevalence: Worldwide, jellyfish cause an estimated 150 000–200 000 envenomations annually, with 3–5 % progressing to systemic allergic reactions. In the United States, the National Oceanic and Atmospheric Administration (NOAA) reports roughly 10 000 stings per year, with 300–500 cases of anaphylaxis requiring emergency care ².

Symptoms

Anaphylaxis is a multi‑system reaction that typically begins within minutes of the sting, but delayed onset (up to 2 hours) is possible. The following list includes the most common and the less frequent manifestations:

Cutaneous

• Urticaria (hives): Raised, itchy wheals that may spread beyond the sting site.
• Flushing or erythema: Warm, red skin patches.
• Pruritus: Generalized itching.
• Angio‑edema: Swelling of lips, tongue, eyelids, or genitalia.

Respiratory

• Wheezing or whistling breath.
• Shortness of breath, chest tightness.
• Throat tightness, hoarseness, or difficulty speaking.
• Stridor (high‑pitched noise on inhalation).

Cardiovascular

• Rapid pulse (tachycardia) or weak, thready pulse.
• Hypotension (systolic < 90 mmHg or a drop of >30 %).
• Dizziness, fainting, or feeling light‑headed.
• Cold, clammy skin.

Gastrointestinal

• Nausea, vomiting, or abdominal cramps.
• Diarrhea.

Neurologic

• Feeling of impending doom.
• Confusion or loss of consciousness.

Any combination of the above, especially when respiratory or cardiovascular signs are present, constitutes anaphylaxis and warrants immediate emergency treatment.

Causes and Risk Factors

What causes it?

Jellyfish stings inject a complex mixture of toxins (e.g., porins, phospholipases, and neurotoxins) into the skin. In susceptible individuals, these proteins act as allergens and trigger the release of histamine, tryptase, and other mediators from mast cells and basophils, leading to the systemic cascade known as anaphylaxis.

Key risk factors

• Previous anaphylaxis: History of severe allergic reactions to insects, foods, or medications raises the risk.
• Atopic disorders: Asthma, eczema, allergic rhinitis, or food allergies increase sensitization potential.
• Repeated exposure: Frequent swimming or diving in jellyfish‑prone waters can sensitize the immune system.
• Age: Children and young adults tend to have higher exposure rates; elderly patients may have blunted skin signs, delaying recognition.
• Specific species: Box jellyfish (Chironex fleckeri), Portuguese man‑of‑war (Physalia physalis), and Irukandji (Carukia barnesi) are most commonly associated with systemic reactions.
• Medical conditions: Cardiovascular disease or use of beta‑blockers can worsen anaphylactic outcomes.

Diagnosis

Jellyfish sting anaphylaxis is a clinical diagnosis. Rapid assessment is essential, and laboratory testing is adjunctive.

Clinical assessment

• History of recent marine exposure (within 30 minutes to 2 hours) and a visible sting.
• Recognition of the symptom clusters listed above.
• Application of validated criteria (e.g., the World Allergy Organization anaphylaxis algorithm).

Laboratory tests (optional, not for acute decision‑making)

• Serum tryptase: Elevated > 11.4 µg/L within 1–3 hours supports mast cell activation.
• Specific IgE testing: May be performed weeks later to identify sensitization to jellyfish venom.
• Complete blood count (CBC): May show leukocytosis.
• Electrolytes & renal function: Helpful if aggressive fluid resuscitation is needed.

Treatment Options

Timely treatment follows the standard anaphylaxis protocol, with additional measures for jellyfish venom.

First‑line emergency treatment

1. Intramuscular epinephrine 0.3 mg (1:1,000) for adults, 0.15 mg for children < 30 kg, injected into the mid‑outer thigh. Repeat every 5‑15 minutes if symptoms persist.
2. Positioning: Lay the patient supine with legs elevated (unless respiratory distress dictates a seated position).
3. Oxygen: High‑flow (10‑15 L/min) via non‑rebreather mask.
4. Airway management: Prepare for advanced airway (intubation) if signs of airway obstruction develop.

Adjunctive therapies

• Antihistamines: Diphenhydramine 25‑50 mg IV/IM or cetirizine 10 mg PO; helpful for cutaneous symptoms but not first‑line for airway or cardiovascular compromise.
• Corticosteroids: Methylprednisolone 125 mg IV (or equivalent); may reduce biphasic reactions though evidence is modest.
• Intravenous fluids: 1–2 L crystalloid bolus (e.g., normal saline) for hypotension.
• Vasopressors: Norepinephrine infusion if hypotension persists despite fluids and epinephrine.

Jellyfish‑specific measures

• Vinegar (5 % acetic acid): For most stings, rinse the area with vinegar for at least 30 seconds to inhibit further nematocyst discharge. Do not use fresh water, which can trigger more firing.
• Heat application: Immersing the sting site in hot water (45‑45 °C) for 20‑30 minutes may denature toxins and reduce pain.
• Removal of tentacles: Using tweezers (not bare hands) after vinegar rinse.

Long‑term management

• Prescription epinephrine auto‑injector (EAI): Carry at least two devices (e.g., EpiPen®, Auvi‑Q®).
• Allergy referral: Formal evaluation within 1–2 weeks for IgE testing, education, and possible venom immunotherapy (available in limited specialty centers).
• Medical alert identification: Bracelets or cards noting “Jellyfish sting anaphylaxis.”

Living with Jellyfish Sting Anaphylaxis

While the possibility of a severe reaction can be anxiety‑provoking, many patients lead normal lives with careful planning.

Daily management tips

• Always keep your EAIs in a readily accessible place (e.g., beach bag, purse, car).
• Rotate EAIs before expiration dates; most are good for 12–18 months.
>
• Practice the injection technique quarterly using a trainer device.
• Maintain a personal anaphylaxis action plan—a one‑page sheet that outlines when to use epinephrine, when to call 911, and emergency contacts.
• Inform friends, family, and coworkers about your allergy and where the auto‑injectors are stored.
• Wear a waterproof medical alert bracelet when swimming, diving, or engaging in water sports.
• Keep a small, waterproof bag with vinegar and a pair of tweezers for immediate first‑aid of stings.
• Stay hydrated and avoid alcohol before swimming, as dehydration can worsen hypotension.

Psychological considerations

Fear of another reaction can limit water activities and affect mental health. Cognitive‑behavioral therapy (CBT) and support groups for marine‑related allergies can improve coping skills.

Prevention

Preventing both the sting and the subsequent anaphylaxis is the best strategy.

• Check local advisories: Many coastal agencies post jellyfish bloom alerts.
• Wear protective gear: Full‑body “stinger suits” made of Lycra or neoprene are effective against Box and Irukandji jellyfish.
• Use barrier creams: Some commercial products contain silicones that reduce nematocyst penetration.
• Avoid peak jellyfish times: Early morning and late afternoon are high‑risk periods in many regions.
• Stay in designated swimming areas: These zones are often monitored and may have netting.
• Never touch or pick up dead jellyfish: Tentacles can still fire.
• Educate children: Teach them to alert an adult if they see a jellyfish.

Complications

If anaphylaxis is not promptly treated, serious complications can arise:

• Respiratory failure: Airway edema or bronchospasm leading to hypoxia.
• Cardiogenic or distributive shock: Severe hypotension may cause organ ischemia.
• Arrhythmias: Catecholamine surge from untreated anaphylaxis.
• Neurological injury: Anoxic brain injury after prolonged hypoxia.
• Biphasic reaction: Recurrence of symptoms 4–12 hours after the initial episode.
• Renal failure: Secondary to hypoperfusion.

Mortality rates for anaphylaxis overall are estimated at 0.5–1 % in the United States, but deaths specifically from jellyfish‑related anaphylaxis are rare (< 0.1 %) yet still preventable with rapid epinephrine administration ³.

When to Seek Emergency Care

---

Sources:

1. Centers for Disease Control and Prevention. Jellyfish Stings – Frequently Asked Questions. Accessed May 2026.
2. National Oceanic and Atmospheric Administration. Jellyfish Statistics and Public Health Impact. 2024.
3. World Allergy Organization. Anaphylaxis Guidelines. 2023.
4. Mayo Clinic. Anaphylaxis. Updated 2025.
5. Cleveland Clinic. Jellyfish Sting: Symptoms and Treatment. 2024.